• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖/羧甲基壳聚糖纳米粒用于高效、安全的口服抗癌药物递送:体外和体内评价。

Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.

机构信息

College of Marine Life Science, Ocean University of China, Qingdao 266003, PR China.

出版信息

Int J Pharm. 2013 Nov 30;457(1):158-67. doi: 10.1016/j.ijpharm.2013.07.079. Epub 2013 Sep 9.

DOI:10.1016/j.ijpharm.2013.07.079
PMID:24029170
Abstract

The present study investigated the ability of a polyelectrolyte complex (CS/CMCS-NPs), composed of chitosan (CS) and o-carboxymeymethy chitosan (CMCS) as a pH responsive carrier for oral delivery of doxorubicin hydrochloride (DOX). The obtained CS/CMCS-NPs were characterized for various parameters including morphology, particle size, zeta potential, entrapment efficiency and stability under the simulated GI tract conditions. The pH responsive stability of the DOX-loaded CS/CMCS nanoparticles (DOX:CS/CMCS-NPs) determined the drug release rate, which was lower in acidic pH than the neutral. Ex vivo intestinal adhesion and permeation indicated DOX:CS/CMCS-NGs were able to enhance absorption of DOX throughout the entire small intestine, especially in jejunum and ileum. Oral administration of DOX:CS/CMCS-NPs was effective to deliver DOX into blood, giving an absolute bioavailability of 42%. The tissue distribution and toxicity of DOX:CS/CMCS-NPs in rats showed low level of DOX in heart and kidney, and obviously decreased cardiac and renal toxicities. These results indicated CS/CMCS-NPs were highly efficient and safe as an oral delivery system for DOX.

摘要

本研究考察了由壳聚糖(CS)和羧甲基壳聚糖(CMCS)组成的聚电解质复合物(CS/CMCS-NPs)作为盐酸阿霉素(DOX)口服递送的 pH 响应载体的能力。所得到的 CS/CMCS-NPs 进行了各种参数的表征,包括形态、粒径、Zeta 电位、包封效率和在模拟胃肠道条件下的稳定性。载药 CS/CMCS 纳米粒(DOX:CS/CMCS-NPs)的 pH 响应稳定性决定了药物释放速率,在酸性 pH 下低于中性 pH。离体肠道黏附和渗透实验表明,DOX:CS/CMCS-NGs 能够增强 DOX 在整个小肠中的吸收,尤其是在空肠和回肠中。DOX:CS/CMCS-NPs 的口服给药能够有效地将 DOX 递送到血液中,绝对生物利用度为 42%。在大鼠中的组织分布和毒性研究表明,DOX:CS/CMCS-NPs 在心脏和肾脏中的 DOX 水平较低,并且明显降低了心脏和肾脏的毒性。这些结果表明,CS/CMCS-NPs 作为 DOX 的口服递送系统具有高效和安全的特点。

相似文献

1
Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.壳聚糖/羧甲基壳聚糖纳米粒用于高效、安全的口服抗癌药物递送:体外和体内评价。
Int J Pharm. 2013 Nov 30;457(1):158-67. doi: 10.1016/j.ijpharm.2013.07.079. Epub 2013 Sep 9.
2
Transport mechanism of doxorubicin loaded chitosan based nanogels across intestinal epithelium.载阿霉素壳聚糖纳米凝胶的跨肠道上皮转运机制。
Eur J Pharm Biopharm. 2014 May;87(1):197-207. doi: 10.1016/j.ejpb.2013.11.007. Epub 2013 Dec 4.
3
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.海藻酸包覆壳聚糖核壳纳米粒经口递送依诺肝素:体外与体内评价。
Int J Pharm. 2013 Nov 1;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. Epub 2013 Aug 29.
4
Multilayer sodium alginate beads with porous core containing chitosan based nanoparticles for oral delivery of anticancer drug.具有含壳聚糖基纳米颗粒的多孔核心的多层海藻酸钠珠粒用于抗癌药物的口服递送。
Int J Biol Macromol. 2016 Apr;85:1-8. doi: 10.1016/j.ijbiomac.2015.12.064. Epub 2015 Dec 24.
5
A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.一种通过双pH敏感聚电解质复合纳米颗粒进行口服化疗的策略,以实现胃部存活能力、肠道通透性、血液动力学稳定性和细胞内活性。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):107-17. doi: 10.1016/j.ejpb.2015.10.010. Epub 2015 Oct 26.
6
Immobilization of coacervate microcapsules in multilayer sodium alginate beads for efficient oral anticancer drug delivery.共凝聚体微胶囊在多层海藻酸钠珠粒中的固定化用于高效口服抗癌药物递送。
Biomacromolecules. 2014 Mar 10;15(3):985-96. doi: 10.1021/bm401890x. Epub 2014 Feb 19.
7
Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor.多层微分散系统作为盐酸多柔比星和P-糖蛋白抑制剂共同递送的口服载体
Int J Biol Macromol. 2017 Jan;94(Pt A):170-180. doi: 10.1016/j.ijbiomac.2016.10.012. Epub 2016 Oct 8.
8
Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.盐酸多柔比星脂质体,提高口服生物利用度。
Int J Pharm. 2012 Feb 28;423(2):554-61. doi: 10.1016/j.ijpharm.2011.11.035. Epub 2011 Dec 2.
9
[Polyelectrolyte layer-by-layer assembled lipid nanoparticles for improving oral absorption of doxorubicin].用于改善阿霉素口服吸收的聚电解质层层组装脂质纳米粒
Yao Xue Xue Bao. 2016 Jul;51(7):1136-43.
10
Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.一种新型亲水性抗肿瘤药物潜在载体的设计与评价:黑木耳多糖-壳聚糖纳米粒作为盐酸多柔比星的递送系统
Int J Pharm. 2016 Sep 10;511(1):267-275. doi: 10.1016/j.ijpharm.2016.07.026. Epub 2016 Jul 14.

引用本文的文献

1
Chitosan-Nanoparticles Mitigate Cadmium Chloride Hepatorenal Toxicity in BALB/C Mice Via Amendment of Nrf2/HO-1 and NF-κB/iNOS Signaling Pathways.壳聚糖纳米颗粒通过调节Nrf2/HO-1和NF-κB/iNOS信号通路减轻BALB/C小鼠的氯化镉肝肾毒性。
Biol Trace Elem Res. 2025 Aug 25. doi: 10.1007/s12011-025-04749-0.
2
Biological and computational assessments of thiazole derivative-reinforced bile salt enriched nano carriers: a new gate in targeting SARS-CoV-2 spike protein.噻唑衍生物增强的富含胆盐纳米载体的生物学和计算评估:靶向SARS-CoV-2刺突蛋白的新途径
RSC Adv. 2024 Dec 9;14(52):38778-38795. doi: 10.1039/d4ra07316a. eCollection 2024 Dec 3.
3
Form Equals Function: Influence of Coacervate Architecture on Drug Delivery Applications.
形式决定功能:凝聚体形貌对药物传递应用的影响。
ACS Biomater Sci Eng. 2024 Nov 11;10(11):6766-6789. doi: 10.1021/acsbiomaterials.4c01105. Epub 2024 Oct 18.
4
Biodegradable Polymeric Nanoparticle-Based Drug Delivery Systems: Comprehensive Overview, Perspectives and Challenges.基于可生物降解聚合物纳米颗粒的药物递送系统:全面综述、前景与挑战
Polymers (Basel). 2024 Sep 7;16(17):2536. doi: 10.3390/polym16172536.
5
The Chemical Modification to Improve Solubility of Chitosan and Its Derivatives Application, Preparation Method, Toxicity as a Nanoparticles.改善壳聚糖及其衍生物溶解度的化学修饰、应用、制备方法、作为纳米颗粒的毒性
Nanotechnol Sci Appl. 2024 Mar 7;17:41-57. doi: 10.2147/NSA.S450026. eCollection 2024.
6
Chitosan nanoparticle toxicity: A comprehensive literature review of and assessments for medical applications.壳聚糖纳米颗粒毒性:医学应用的体外和体内评估综合文献综述
Toxicol Rep. 2023 Jun 29;11:83-106. doi: 10.1016/j.toxrep.2023.06.012. eCollection 2023 Dec.
7
Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization.壳聚糖纳米载体在黏膜免疫疫苗学中的效率
Vaccines (Basel). 2023 Aug 6;11(8):1333. doi: 10.3390/vaccines11081333.
8
Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy.肿瘤微环境响应性球形核酸纳米粒子用于增强化学免疫治疗。
J Nanobiotechnology. 2023 May 26;21(1):171. doi: 10.1186/s12951-023-01916-0.
9
Preparation and Characterization of Multilayer pH-Responsive Hydrogel Loaded Peptides.多层pH响应性载肽水凝胶的制备与表征
Foods. 2023 Mar 31;12(7):1481. doi: 10.3390/foods12071481.
10
Synergistic cytotoxicity effect of the combination of chitosan nanoencapsulated imatinib mesylate and quercetin in BCR-ABL positive K562 cells.壳聚糖纳米包封甲磺酸伊马替尼与槲皮素联合应用对BCR-ABL阳性K562细胞的协同细胞毒性作用
Iran J Basic Med Sci. 2023 Mar;26(3):359-366. doi: 10.22038/IJBMS.2023.68472.14934.